2015 International Peroxisome & Leukodystrophy Meeting

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The 2015 International Peroxisome and Leukodystrophe Meeting will be held July 15-17 in Omaha, Nebraska.

 

Learn about the invited presenters and their work: Presenter bios.

 

All sessions will take place at Embassy Suites Downtown/Old Market, 555 South 10th Street, Omaha, NE

 

Wednesday, July 15

➢ 4:00 p.m. - Arrivals & Check In

➢ 5:30 - 7:30 p.m. - Complimentary Managers' Reception, Embassy Suites, Dinner on your own

 

Thursday, July 16

➢ 6:00 - 8:00 a.m. - Complimentary Breakfast, Hotel Atrium

➢ 8:00 AM - Introductions and Welcomes - Bob Rauner, President; ULF William Rizzo, M.D., Chair, Medical & Scientific Advisory Board; ULF Ann Moser, B.A., Vice-Chair, Medical & Scientific Advisory Board, ULF

➢ 8:15 AM - Marjo van der Knaap, M.D., Ph.D. - VU University Medical Center, Amsterdam, The Netherlands, VWM mouse models and disease mechanisms

➢ 8:45 AM - Genevieve Bernard, M.D., MSc, FRCPC - McGill University, Montreal, Canada, POLR3-related leukodystrophy: research update on an international collaboration

➢ 9:15 AM - Gary Smith, M.D. / John Fink, M.D. - University of Michigan, Ann Arbor, MI, Disease Specific Human Embryonic Stem Cell Modeling of Leukodystrophies

➢ 9:45 AM - Fabrice Dabertrand, Ph.D. - University of Vermont, Burlington, VT, 2014 ULF/CADASIL research award recipient, Disruption of astrocytic calcium signaling during neurovascular coupling in genetic model of small vessel disease

➢ 10:15 AM - Break

➢ 10:30 AM - Andrea DeBarber, Ph.D. - Oregon Health & Science University, Portland, OR, Toward newborn screening for Cerebrotendinous Xanthomatosis

➢ 11:00 AM - Josh Bonkowsky, M.D., Ph.D. - University of Utah, Salt Lake City, UT, From Tank to Bedside for Leukodystrophies

➢ 11:30 AM - Charles Abrams, M.D. - State University of New York, Downstate Medical Center, Brooklyn, NY, Connexin 47 Associated Leukodystrophy

➢ 12:00 PM - Lunch

➢ 1:00 PM - GFPD Welcome/Peroxisome Biology and Peroxisomal Disease - Shannon Butalla/Mousumi Bose, GFPD Board of Directors; Richard Rachubinski/ Nancy Braverman, GFPD Medical & Scientific Advisory Board

➢ 1:15 PM - Richard Rachubinski, Ph.D. - University of Alberta, Edmonton, Alberta, Canada, Molecular biology of peroxisomes to date

➢ 1:45 PM - Ronald J.A. Wanders, Ph.D. - University of Amsterdam, The Netherlands, Clinical and biochemical accomplishments to date

➢ 2:15 PM - John Aitchison, Ph.D. - Seattle Biomedical Research Institute, WA, Systems biology and how perturbations in peroxisome metabolism can be captured to help understand disease

➢ 2:45 PM - Break

➢ 3:00 PM - Ralf Erdmann, Ph.D. - Ruhr Universitat, Bochum, Germany, Crystallization of the PEX1-PEX6 protein complex and how this can help drug identification for mutations in these proteins

➢ 3:30 PM - Gabriele Dodt, M.D. - University of Tuebingen, Germany, An update on the biology of peroxisome proteins involved in a new peroxisome formation

➢ 4:00 PM - Ewald Hettema, Ph.D. - University of Sheffield, UK, Update on peroxisome fission and division

➢ 4:30 PM - Break

➢ 5:30 - 7:30 PM - Student Poster Session, Complimentary Managers' Reception with light dinner

 

Friday, July 17

➢ 6:00 - 8:30 AM - Complimentary Breakfast, Hotel Atrium

➢ 8:30 AM - Peter K. Kim, Ph.D. - University of Toronto, Ontario, Canada, Autophagy inhibitors as a method to increase peroxisome numbers for therapy

➢ 9:00 AM - Joseph Hacia, Ph.D. - University of Southern California, Los Angeles, CA, High throughput drug screening to identify drugs that rescue peroxisome defects

➢ 9:30 AM - Hans Waterham, Ph.D. - University of Amsterdam, The Netherlands; Steven Steinberg, Ph.D., FACMG - Johns Hopkins University, Baltimore, MD, An update on PEX mutations in patients and the PEX1-G844D mouse model

➢ 10:00 AM - Steven Steinberg, Ph.D., FACNG - Johns Hopkins University School of Medicine, Baltimore, MD, Hypomorphic PEX alleles

➢ 10:30 AM - Break

➢ 10:45 AM - Troy Lund, M.D., Ph.D. - University of Minnesota, Minneapolis, MN, Hematological findings in the PEX1-G844D model

➢ 11:15 AM - Nancy Braverman, M.D., M.S. - McGill University, Montreal, Quebec, Canada, Betaine and diosmin studies: of mice and men

➢ 12:00 PM - Lunch

➢ 1:00 PM - Andrew Simmonds, Ph.D. - University of Alberta, Edmonton, Alberta, Canada, Fly models for PEX1 peroxisome diseases

➢ 1:30 PM - Michael Wangler, M.D., M.S - Baylor University, Houston, Fly models for other PEX mutations

➢ 2:00 PM - Bwee Tien Poll-The, M.D., Ph.D. - University of Amsterdam, The Netherlands, Zellweger spectrum disorders: cohort studies and future perspectives

➢2:30 PM - Yukio Fujiki, Ph.D. - Kyushu University, Japan, Plasmalogen homeostasis and peroxisomal disorders

➢ 3:00 PM - Break

➢ 4:00 - 6:00 - All participants - A roundtable discussion: From basic science to novel ideas for therapy

➢ 5:30 - 7:30 - Complimentary Managers' Reception, Embassy Suites

➢ 6:30 - 9:30 - Dinner with the GFPD Community, Embassy Suites

 

Saturday, July 18 – Monday July 20 – GFPD Family & Scientific Conference

© 2018 by GFPD. Proudly created by CAZ Media Design

 Images on this site were contributed by families and may not be used without permission.

guide-Star-Seal2018-gold-grey.png
2018-Nord-Member-grey.png
GFPD-Logo.png
  • GFPD on Facebook
  • GFPD on Instagram
  • GFPD on Youtube
  • GFPD Amazon Smile
  • the GFPD Linkedin
  • the GFPD Twitter